{"SPADE_UN_13556": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13556", "Peptide Name": "IBP02V5", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "SLTQINASVVNIQKEIDRLNEVAKNLNESLIDLQEL", "Sequence Length": 36, "UniProt Entry": "No entry found", "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antiviral(SARS-CoV-2)"], "Target Organism": "[Ref.34344868]Virus:SARS-CoV-2:inhibition of SARS-CoV-2 S protein-mediated cell-cell fusion(IC50=2.1±0.5 nM);inhibition of SARS-CoV-2 pseudovirus infection in 293T/ACE2 cells(IC50=21 nM);inhibition of SARS-CoV-2 pseudovirus infection in Huh-7 cells(IC50=23.5 nM);SARS-CoV-2 D614G:inhibition of S protein-mediated cell-cell fusion(IC50=1.3±0.1 nM);inhibition of pseudovirus infection in 293T/ACE2 cells(IC50=98.8 nM);inhibition of pseudovirus infection in Huh-7 cells(IC50=27.5 nM);SARS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=65.9±13.2 nM);MERS-CoV:inhibition of pseudovirus infection in Huh-7 cells(IC50=68.4±9.7 nM);HCoV-NL63:inhibition of pseudovirus infection in Huh-7 cells(IC50=70.8±8.7 nM);HCoV-229E:inhibition of pseudovirus infection in Huh-7 cells(IC50=1128.4±148.6 nM).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "[Ref.34344868]No significant cytotoxicity in both 293T/ACE2 and Huh-7 cells at a concentration of 10 μM.", "Binding Target": "liposomes", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "PEG8-K(Chol)", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C175H299N49O61", "Mass": 4065.54, "PI": 4.36, "Net Charge": -3, "Hydrophobicity": -0.21, "Half Life": "Mammalian:1.9 hourYeast:>20 hourE.coli:>10 hour", "Comments": "The peptide is a fusion inhibitor against SARS-CoV-2.", "Literature": [{"Title": "SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses.", "Pubmed ID": "34344868", "Reference": "Signal Transduct Target Ther. 2021 Aug 3;6(1)294.", "Author": "Zhu Y, Yu D, Hu Y, Wu T, Chong H, He Y.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=34344868"}], "Frequent Amino Acids": "LNE", "Absent Amino Acids": "CFGHMOPUWY", "Basic Residues": 3, "Acidic Residues": 6, "Hydrophobic Residues": 15, "Polar Residues": 20, "Positive Residues": 3, "Negative Residues": 6, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_13523", "Similarity": 1.0, "Sequence": "INASVVNIQKEIDRLNEVAKNLNESLIDLQELGK"}, {"SPADE_ID": "SPADE_UN_13524", "Similarity": 1.0, "Sequence": "SVVNIQKEIDRLNEVAKNLNESLIDLQELGK"}, {"SPADE_ID": "SPADE_UN_13553", "Similarity": 1.0, "Sequence": "SVVNIQKEIDRLNEVAKNLNESLIDLQELGKYEQYIK"}]}}}